Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis

British Journal of Cancer

Volumn 114, Issue 2, 2016, Pages 199-206

  Kim, Sun A ^a   Inamura, Kentaro ^a,b   Yamauchi, Mai ^a   Nishihara, Reiko ^c   Mima, Kosuke ^a,c   Sukawa, Yasutaka ^a   Li, Tingting ^a,d   Yasunari, Mika ^a   Morikawa, Teppei ^e   Fitzgerald, Kathryn C ^c   Fuchs, Charles S ^a,f   Wu, Kana ^c   Chan, Andrew T ^f,g   Zhang, Xuehong ^a   Ogino, Shuji ^a,c,h   Qian, Zhi Rong ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CHINESE PLA GENERAL HOSPITAL   (China)

^e UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^f HARVARD MEDICAL SCHOOL   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; K RAS PROTEIN; LINE 1 PROTEIN; PIK3CA PROTEIN; PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; BRAF PROTEIN, HUMAN; CADHERIN; CDH1 PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; MUTL PROTEIN HOMOLOG 1; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN P21; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR GROWTH; CANCER STAGING; CARCINOMA; CELL MOTION; COHORT ANALYSIS; COLORECTAL TUMOR; DISEASE COURSE; DNA METHYLATION; FACTUAL DATABASE; GENETICS; LONG INTERSPERSED REPEAT; LYMPH NODE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PROGNOSIS; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STATISTICAL MODEL; TUMOR INVASION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; BIOMARKERS, TUMOR; CADHERINS; CARCINOMA; CELL MOVEMENT; COHORT STUDIES; COLORECTAL NEOPLASMS; CPG ISLANDS; DATABASES, FACTUAL; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTL PROTEIN HOMOLOG 1; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEAR PROTEINS; ODDS RATIO; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 84955171910     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.347     Document Type: Article

References (38)

1. Bondi J, Bukholm G, Nesland JM, Bakka A, Bukholm IR (2006) An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients. Int J Colorectal Dis 21(3): 231-237.
2. Chen X, Wang Y, Xia H, Wang Q, Jiang X, Lin Z, Ma Y, Yang Y, Hu M (2012) Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis. Mol Biol Rep 39(6): 6707-6714.
3. Cianchi F, Messerini L, Comin CE, Boddi V, Perna F, Perigli G, Cortesini C (2007) Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model. Dis Colon Rectum 50(9): 1332-1341.
4. Fadare O, Reddy H, Wang J, Hileeto D, Schwartz PE, Zheng W (2005) E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: A tissue microarray study of 147 cases. World J Surg Oncol 3: 38.
5. Filiz AI, Senol Z, Sucullu I, Kurt Y, Demirbas S, Akin ML (2010) The survival effect of E-cadherin and catenins in colorectal carcinomas. Colorectal Dis 12(12): 1223-1230.
6. He X, Chen Z, Jia M, Zhao X (2013) Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. PLoS One 8(7): e70858.
7. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22(2): 271-282.
8. Imamura Y, Lochhead P, Yamauchi M, Kuchiba A, Qian ZR, Liao X, Nishihara R, Jung S, Wu K, Nosho K, Wang YE, Peng S, Bass AJ, Haigis KM, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S (2014) Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer 13: 135.
9. Irahara N, Baba Y, Nosho K, Shima K, Yan L, Dias-Santagata D, Iafrate AJ, Fuchs CS, Haigis KM, Ogino S (2010) NRAS mutations are rare in colorectal cancer. Diagn Mol Pathol 19(3): 157-163.
10. Jie D, Zhongmin Z, Guoqing L, Sheng L, Yi Z, Jing W, Liang Z (2013) Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Dig Dis Sci 58(6): 1581-1589.
11. Jonker DJ, Karapetis CS, Harbison C, O'Callaghan CJ, Tu D, Simes RJ, Malone DP, Langer C, Tebbutt N, Price TJ, Shapiro J, Siu LL, Wong RP, Bjarnason G, Moore MJ, Zalcberg JR, Khambata-Ford S (2014) Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. Br J Cancer 110(3): 648-655.
12. Karamitopoulou E, Zlobec I, Koelzer VH, Langer R, Dawson H, Lugli A (2015) Tumour border configuration in colorectal cancer: proposal for an alternative scoring system based on the percentage of infiltrating margin. Histopathology 67(4): 464-473.
13. Karamitopoulou E, Zlobec I, Patsouris E, Peros G, Lugli A (2011) Loss of E-cadherin independently predicts the lymph node status in colorectal cancer. Pathology 43(2): 133-137.
14. Keum M, Lim S-B, Kim SA, Yoon YS, Kim CW, Yu CS, Kim JC (2012) Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer. J Korean Soc Coloproctol 28(1): 49-55.
15. Kroepil F, Fluegen G, Vallbohmer D, Baldus SE, Dizdar L, Raffel AM, Hafner D, Stoecklein NH, Knoefel WT (2013) Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters. BMC Cancer 13: 145.
16. Kwak JM, Min BW, Lee JH, Choi JS, Lee SI, Park SS, Kim J, Um JW, Kim SH, Moon HY (2007) The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer. Dis Colon Rectum 50(11): 1873-1880.
17. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367(17): 1596-1606.
18. Lochhead P, Kuchiba A, Imamura Y, Liao X, Yamauchi M, Nishihara R, Qian ZR, Morikawa T, Shen J, Meyerhardt JA, Fuchs CS, Ogino S (2013) Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst 105(15): 1151-1156.
19. Lu MH, Huang CC, Pan MR, Chen HH, Hung WC (2012) Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin Cancer Res 18(23): 6416-6425.
20. Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L, Jass JR (2007) Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: A tissue microarraybased analysis. Histopathology 50(4): 453-464.
21. Morikawa T, Kuchiba A, Qian ZR, Mino-Kenudson M, Hornick JL, Yamauchi M, Imamura Y, Liao X, Nishihara R, Meyerhardt JA, Fuchs CS, Ogino S (2012) Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol 19(6): 1944-1953.
22. Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, Nosho K, Chan AT, Giovannucci E, Fuchs CS, Ogino S (2011) Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 305(16): 1685-1694.
23. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S (2008) Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large populationbased sample. PLoS One 3(11): e3698.
24. Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M, Fuchs CS (2006a) Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 19(1): 59-68.
25. Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS (2006b) Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Neoplasia 8(6): 458-464.
26. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS (2006c) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 8(2): 209-217.
27. Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, Mino-Kenudson M, Lauwers GY, Loda M, Fuchs CS (2005a) Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn 7(3): 413-421.
28. Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS (2007) Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9(3): 305-314.
29. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS (2008) LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 122(12): 2767-2773.
30. Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS (2005b) Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Clin Cancer Res 11(18): 6650-6656.
31. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS (2009) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58(1): 90-96.
32. Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N, Kudo E (2007) Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Modern Pathol 20(12): 1269-1277.
33. Roman R, Verdu M, Calvo M, Vidal A, Sanjuan X, Jimeno M, Salas A, Autonell J, Trias I, Gonzalez M, Garcia B, Rodon N, Puig X (2010) Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model. Virchows Arch 456(5): 533-541.
34. Toth L, Andras C, Molnar C, Tanyi M, Csiki Z, Molnar P, Szanto J (2012) Investigation of beta-catenin and E-cadherin expression in Dukes B2 stage colorectal cancer with tissue microarray method. Is it a marker of metastatic potential in rectal cancer? Pathol Oncol Res 18(2): 429-437.
35. Tsanou E, Peschos D, Batistatou A, Charalabopoulos A, Charalabopoulos K (2008) The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 28(6A): 3815-3826.
36. Zlobec I, Baker K, Minoo P, Hayashi S, Terracciano L, Lugli A (2009) Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Cancer 115(17): 4021-4029.
37. Zlobec I, Hadrich M, Dawson H, Koelzer VH, Borner M, Mallaev M, Schnuriger B, Inderbitzin D, Lugli A (2014) Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br J Cancer 110(4): 1008-1013.
38. Zlobec I, Lugli A, Baker K, Roth S, Minoo P, Hayashi S, Terracciano L, Jass JR (2007) Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer. J Pathol 212(3): 260-268.